SERPINE1 and COVID-19: A cohort study by von Meijenfeldt et al. at Danderyd Hospital Stockholm, Sweden, that recruited 52 COVID-19 patients found a very low PAI-1 levels [3.15 (0.85–5.58)] after four months of follow-up [67].